CRD-BP/IMP1 Expression Characterizes Cord Blood CD34+ Stem Cells and Affects c-myc and IGF-II Expression in MCF-7 Cancer Cells

This publication has 39 references indexed in Scilit:

• Dwarfism and Impaired Gut Development in Insulin-Like Growth Factor II mRNA-Binding Protein 1-Deficient Mice
  Molecular and Cellular Biology, 2004
• The insulin‐like growth factor mRNA binding‐protein IMP‐1 and the Ras‐regulatory protein G3BP associate with tau mRNA and HuD protein in differentiated P19 neuronal cells
  Journal of Neurochemistry, 2004
• Nuclear transit of human zipcode-binding protein IMP1
  Biochemical Journal, 2003
• 8q24 Copy number gains and expression of the c‐myc mRNA stabilizing protein CRD‐BP in primary breast carcinomas
  International Journal of Cancer, 2003
• C‐MYC and IGF‐II mRNA‐binding protein (CRD‐BP/IMP‐1) in benign and malignant mesenchymal tumors
  International Journal of Cancer, 2001
• Overexpression of an mRNA-binding protein in human colorectal cancer
  Oncogene, 2001
• H19 RNA Binds Four Molecules of Insulin-like Growth Factor II mRNA-binding Protein
  Journal of Biological Chemistry, 2000
• A Family of Insulin-Like Growth Factor II mRNA-Binding Proteins Represses Translation in Late Development
  Molecular and Cellular Biology, 1999
• Developmental regulation of CRD-BP, an RNA-binding protein that stabilizes c-myc mRNA in vitro
  Oncogene, 1997
• Control of c-myc mRNA half-life in vitro by a protein capable of binding to a coding region stability determinant.
  Genes & Development, 1992